These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 19879444

  • 21. Clinical implications of the immunomodulatory effects of macrolides on sinusitis.
    Majima Y.
    Am J Med; 2004 Nov 08; 117 Suppl 9A():20S-25S. PubMed ID: 15586560
    [Abstract] [Full Text] [Related]

  • 22. [Conservative therapy of the chronic rhinosinusitis].
    Förster U, Olze H.
    Laryngorhinootologie; 2009 May 08; 88(5):339-55; quiz 356. PubMed ID: 19391075
    [Abstract] [Full Text] [Related]

  • 23. The effect of topical amphotericin B on inflammatory markers in patients with chronic rhinosinusitis: a multicenter randomized controlled study.
    Ebbens FA, Georgalas C, Luiten S, van Drunen CM, Badia L, Scadding GK, Hellings PW, Jorissen M, Mullol J, Cardesin A, Bachert C, van Zele TP, Lund VJ, Fokkens WJ.
    Laryngoscope; 2009 Feb 08; 119(2):401-8. PubMed ID: 19160404
    [Abstract] [Full Text] [Related]

  • 24. Clinical implications of the immunomodulatory effects of macrolides.
    Tamaoki J, Kadota J, Takizawa H.
    Am J Med; 2004 Nov 08; 117 Suppl 9A():5S-11S. PubMed ID: 15586558
    [Abstract] [Full Text] [Related]

  • 25. Innate immunity of the sinonasal cavity and its role in chronic rhinosinusitis.
    Ramanathan M, Lane AP.
    Otolaryngol Head Neck Surg; 2007 Mar 08; 136(3):348-56. PubMed ID: 17321858
    [Abstract] [Full Text] [Related]

  • 26. Nasal biomarker profiles in acute and chronic rhinosinusitis.
    Riechelmann H, Deutschle T, Rozsasi A, Keck T, Polzehl D, Bürner H.
    Clin Exp Allergy; 2005 Sep 08; 35(9):1186-91. PubMed ID: 16164446
    [Abstract] [Full Text] [Related]

  • 27. The design of novel classes of macrolides for neutrophil-dominated inflammatory diseases.
    Eraković Haber V, Bosnar M, Kragol G.
    Future Med Chem; 2014 Apr 08; 6(6):657-74. PubMed ID: 24895894
    [Abstract] [Full Text] [Related]

  • 28. PAR-2 activation regulates IL-8 and GRO-alpha synthesis by NF-kappaB, but not RANTES, IL-6, eotaxin or TARC expression in nasal epithelium.
    Rudack C, Steinhoff M, Mooren F, Buddenkotte J, Becker K, von Eiff C, Sachse F.
    Clin Exp Allergy; 2007 Jul 08; 37(7):1009-22. PubMed ID: 17581194
    [Abstract] [Full Text] [Related]

  • 29. Allergy and chronic rhinosinusitis.
    Krouse JH.
    Otolaryngol Clin North Am; 2005 Dec 08; 38(6):1257-66, ix-x. PubMed ID: 16326183
    [Abstract] [Full Text] [Related]

  • 30. Long-term antibiotics for Chronic Rhinosinusitis: changing views.
    Fokkens WJ.
    Rhinology; 2019 Aug 01; 57(4):241. PubMed ID: 31374113
    [Abstract] [Full Text] [Related]

  • 31. The office management of recalcitrant rhinosinusitis.
    Zacharek MA, Hwang PH, Fong KJ.
    Otolaryngol Clin North Am; 2004 Apr 01; 37(2):365-79. PubMed ID: 15064068
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Important research questions in allergy and related diseases: 3-chronic rhinosinusitis and nasal polyposis - a GALEN study.
    Bachert C, Van Bruaene N, Toskala E, Zhang N, Olze H, Scadding G, Van Drunen CM, Mullol J, Cardell L, Gevaert P, Van Zele T, Claeys S, Halldén C, Kostamo K, Foerster U, Kowalski M, Bieniek K, Olszewska-Ziaber A, Nizankowska-Mogilnicka E, Szczeklik A, Swierczynska M, Arcimowicz M, Lund V, Fokkens W, Zuberbier T, Akdis C, Canonica G, Van Cauwenberge P, Burney P, Bousquet J.
    Allergy; 2009 Apr 01; 64(4):520-33. PubMed ID: 19317839
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Inflammatory pathologies of the rhinosinusitis: rationale for the use of anti-inflammatory agents].
    Bellussi L.
    Acta Otorhinolaryngol Ital; 2003 Aug 01; 23(4 Suppl 74):21-5, 37-40. PubMed ID: 15058606
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Innate and acquired immunity and epithelial cell function in chronic rhinosinusitis.
    Schleimer RP, Lane AP, Kim J.
    Clin Allergy Immunol; 2007 Aug 01; 20():51-78. PubMed ID: 17534045
    [Abstract] [Full Text] [Related]

  • 40. Cellular and molecular mechanisms of chronic rhinosinusitis and potential therapeutic strategies: review on cytokines, nuclear factor kappa B and transforming growth factor beta.
    Phan NT, Cabot PJ, Wallwork BD, Cervin AU, Panizza BJ.
    J Laryngol Otol; 2015 Jul 01; 129 Suppl 3():S2-7. PubMed ID: 26073199
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.